Published in Infect Immun on March 01, 2005
Global dissemination of Vibrio parahaemolyticus serotype O3:K6 and its serovariants. Clin Microbiol Rev (2007) 3.36
Vibrio parahaemolyticus cell biology and pathogenicity determinants. Microbes Infect (2011) 1.78
Identification of proteins secreted via Vibrio parahaemolyticus type III secretion system 1. Infect Immun (2006) 1.76
Inflammation and disintegration of intestinal villi in an experimental model for Vibrio parahaemolyticus-induced diarrhea. PLoS Pathog (2012) 1.47
Type III secretion system 1 genes in Vibrio parahaemolyticus are positively regulated by ExsA and negatively regulated by ExsD. Mol Microbiol (2008) 1.34
Complete Genome Sequences of a Clinical Isolate and an Environmental Isolate of Vibrio parahaemolyticus. Genome Announc (2015) 1.25
Development of two animal models to study the function of Vibrio parahaemolyticus type III secretion systems. Infect Immun (2010) 1.04
Roles of thermostable direct hemolysin (TDH) and TDH-related hemolysin (TRH) in Vibrio parahaemolyticus. Front Microbiol (2015) 1.03
Effect on human cells of environmental Vibrio parahaemolyticus strains carrying type III secretion system 2. Infect Immun (2010) 1.01
The Vibrio parahaemolyticus Type III Secretion Systems manipulate host cell MAPK for critical steps in pathogenesis. BMC Microbiol (2010) 0.96
Vibrio parahaemolyticus infection induces modulation of IL-8 secretion through dual pathway via VP1680 in Caco-2 cells. J Infect Dis (2010) 0.96
Vibrio parahaemolyticus inhibition of Rho family GTPase activation requires a functional chromosome I type III secretion system. Infect Immun (2008) 0.96
Vp1659 is a Vibrio parahaemolyticus type III secretion system 1 protein that contributes to translocation of effector proteins needed to induce cytolysis, autophagy, and disruption of actin structure in HeLa cells. J Bacteriol (2010) 0.95
Multivalent adhesion molecule 7 clusters act as signaling platform for host cellular GTPase activation and facilitate epithelial barrier dysfunction. PLoS Pathog (2014) 0.91
Insights into the environmental reservoir of pathogenic Vibrio parahaemolyticus using comparative genomics. Front Microbiol (2015) 0.87
Characterization of the 5'-flanking region and regulation of expression of human anion exchanger SLC26A6. J Cell Biochem (2008) 0.86
Pseudomonas fluorescens alters epithelial permeability and translocates across Caco-2/TC7 intestinal cells. Gut Pathog (2010) 0.82
Screening for a single-chain variable-fragment antibody that can effectively neutralize the cytotoxicity of the Vibrio parahaemolyticus thermolabile hemolysin. Appl Environ Microbiol (2012) 0.81
Comparative genomic analysis of clinical and environmental strains provides insight into the pathogenicity and evolution of Vibrio parahaemolyticus. BMC Genomics (2014) 0.79
Dual function of a bacterial protein as an adhesin and extracellular effector of host GTPase signaling. Small GTPases (2015) 0.78
Prevalence, Molecular Characterization, and Antibiotic Susceptibility of Vibrio parahaemolyticus from Ready-to-Eat Foods in China. Front Microbiol (2016) 0.76
Bile Sensing: The Activation of Vibrio parahaemolyticus Virulence. Front Microbiol (2017) 0.75
Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev (1998) 17.27
Genome sequence of Vibrio parahaemolyticus: a pathogenic mechanism distinct from that of V cholerae. Lancet (2003) 6.95
Current perspectives on the epidemiology and pathogenesis of clinically significant Vibrio spp. Clin Microbiol Rev (1988) 4.76
Emergence of a unique O3:K6 clone of Vibrio parahaemolyticus in Calcutta, India, and isolation of strains from the same clonal group from Southeast Asian travelers arriving in Japan. J Clin Microbiol (1997) 4.53
Molecular epidemiologic evidence for association of thermostable direct hemolysin (TDH) and TDH-related hemolysin of Vibrio parahaemolyticus with gastroenteritis. Infect Immun (1990) 3.17
Intestinal infection with Giardia spp. reduces epithelial barrier function in a myosin light chain kinase-dependent fashion. Gastroenterology (2002) 2.88
Detection of total and hemolysin-producing Vibrio parahaemolyticus in shellfish using multiplex PCR amplification of tl, tdh and trh. J Microbiol Methods (1999) 2.83
Clonal diversity among recently emerged strains of Vibrio parahaemolyticus O3:K6 associated with pandemic spread. J Clin Microbiol (1999) 2.66
Nucleotide sequence of the thermostable direct hemolysin gene of Vibrio parahaemolyticus. J Bacteriol (1985) 2.66
Environmental investigations of Vibrio parahaemolyticus in oysters after outbreaks in Washington, Texas, and New York (1997 and 1998). Appl Environ Microbiol (2000) 2.50
Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut (2003) 2.37
Outbreak of Vibrio parahaemolyticus infections associated with eating raw oysters--Pacific Northwest, 1997. MMWR Morb Mortal Wkly Rep (1998) 2.37
Enterotoxigenicity of Vibrio parahaemolyticus with and without genes encoding thermostable direct hemolysin. Infect Immun (1992) 2.35
In vivo covalent cross-linking of cellular actin by the Vibrio cholerae RTX toxin. EMBO J (2000) 2.32
Vibrio infections on the Gulf Coast: results of first year of regional surveillance. Gulf Coast Vibrio Working Group. J Infect Dis (1993) 2.30
Structural and signalling molecules come together at tight junctions. Curr Opin Cell Biol (1999) 2.16
Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions. Cell Microbiol (2000) 2.16
Sequence variation in the thermostable direct hemolysin-related hemolysin (trh) gene of Vibrio parahaemolyticus. Appl Environ Microbiol (1992) 2.16
Functional coupling of tight junctions and microfilaments in T84 monolayers. Am J Physiol (1988) 2.12
Analysis of the thermostable direct hemolysin (tdh) gene and the tdh-related hemolysin (trh) genes in urease-positive strains of Vibrio parahaemolyticus isolated on the West Coast of the United States. J Clin Microbiol (1997) 2.12
Incidence of Vibrio parahaemolyticus in U.S. coastal waters and oysters. Appl Environ Microbiol (1990) 2.02
Vibrio parahaemolyticus gastroenteritis. An outbreak associated with raw oysters in the Pacific northwest. Diagn Microbiol Infect Dis (1984) 1.96
Enteropathogenic Escherichia coli-induced myosin light chain phosphorylation alters intestinal epithelial permeability. Gastroenterology (1997) 1.86
Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins. Infect Immun (2001) 1.85
Food poisoning due to Vibrio parahaemolyticus. Annu Rev Med (1974) 1.85
Cytotoxicity and enterotoxicity of the thermostable direct hemolysin-deletion mutants of Vibrio parahaemolyticus. Microbiol Immunol (2004) 1.80
Prevalence of the pandemic genotype of Vibrio parahaemolyticus in Dhaka, Bangladesh, and significance of its distribution across different serotypes. J Clin Microbiol (2002) 1.70
Strain-dependent induction of enterocyte apoptosis by Giardia lamblia disrupts epithelial barrier function in a caspase-3-dependent manner. Infect Immun (2002) 1.63
Distinct effects of Vibrio cholerae haemagglutinin/protease on the structure and localization of the tight junction-associated proteins occludin and ZO-1. Cell Microbiol (2000) 1.53
Intestinal barrier function. Curr Opin Clin Nutr Metab Care (2002) 1.51
Vibrio cholerae hemagglutinin/protease (HA/protease) causes morphological changes in cultured epithelial cells and perturbs their paracellular barrier function. Microb Pathog (1996) 1.42
Enterotoxicity and cytotoxicity of Vibrio parahaemolyticus thermostable direct hemolysin in in vitro systems. Infect Immun (2000) 1.39
The thermostable direct hemolysin of Vibrio parahaemolyticus is a pore-forming toxin. Can J Microbiol (1992) 1.26
Molecular, serological, and virulence characteristics of Vibrio parahaemolyticus isolated from environmental, food, and clinical sources in North America and Asia. Appl Environ Microbiol (2003) 1.26
Effect of pH on the production of the Kanagawa hemolysin by Vibrio parahaemolyticus. Infect Immun (1981) 1.24
Molecular physiology and pathophysiology of tight junctions V. assault of the tight junction by enteric pathogens. Am J Physiol Gastrointest Liver Physiol (2000) 1.23
Characterization of a new thermostable direct haemolysin produced by a Kanagawa-phenomenon-negative clinical isolate of Vibrio parahaemolyticus. J Gen Microbiol (1991) 1.22
Cloning and expression in Escherichia coli of Vibrio parahaemolyticus thermostable direct hemolysin and thermolabile hemolysin genes. J Bacteriol (1985) 1.22
Shigella flexneri regulates tight junction-associated proteins in human intestinal epithelial cells. Cell Microbiol (2002) 1.21
Occurrence of the tdh and trh genes in Vibrio parahaemolyticus isolates from waters and raw shellfish collected in two French coastal areas and from seafood imported into France. Int J Food Microbiol (2004) 1.17
Molecular analyses of tight junction physiology: insights and paradoxes. J Membr Biol (1998) 1.15
Enteropathogenic Escherichia coli activates ezrin, which participates in disruption of tight junction barrier function. Infect Immun (2001) 1.06
Construction and characterization of an isogenic mutant of Vibrio parahaemolyticus having a deletion in the thermostable direct hemolysin-related hemolysin gene (trh) J Bacteriol (1994) 1.05
Mechanisms of chloride secretion induced by thermostable direct haemolysin of Vibrio parahaemolyticus in human colonic tissue and a human intestinal epithelial cell line. J Med Microbiol (2000) 1.04
Close proximity of the tdh, trh and ure genes on the chromosome of Vibrio parahaemolyticus. Microbiology (1998) 1.03
Vibrio parahaemolyticus thermostable direct hemolysin modulates cytoskeletal organization and calcium homeostasis in intestinal cultured cells. Infect Immun (1999) 1.03
Calcium-dependent intestinal chloride secretion by Vibrio parahaemolyticus thermostable direct hemolysin in a rabbit model. Gastroenterology (1995) 1.02
Characterization of United States outbreak isolates of Vibrio parahaemolyticus using enterobacterial repetitive intergenic consensus (ERIC) PCR and development of a rapid PCR method for detection of O3:K6 isolates. FEMS Microbiol Lett (2002) 1.01
Cytoskeletal regulation of Caco-2 intestinal monolayer paracellular permeability. J Cell Physiol (1995) 1.00
Vibrio parahaemolyticus thermostable direct hemolysin can induce an apoptotic cell death in Rat-1 cells from inside and outside of the cells. FEMS Microbiol Lett (2001) 1.00
Production of thermostable direct hemolysin by Vibrio parahaemolyticus enhanced by conjugated bile acids. Appl Environ Microbiol (1996) 0.94
Effect of Vibrio parahaemolyticus haemolysin on human erythrocytes. Cell Microbiol (2004) 0.91
Molecular analysis of Vibrio parahaemolyticus isolated from human patients and shellfish during US Pacific north-west outbreaks. Lett Appl Microbiol (2002) 0.87
Bacterial causes of AIDS-associated diarrhea in Thailand. Southeast Asian J Trop Med Public Health (2001) 0.83
Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand. Lancet (2005) 3.01
Biofilm bacteria: formation and comparative susceptibility to antibiotics. Can J Vet Res (2002) 2.20
Antipsychotics and the risk of type 2 diabetes mellitus in children and youth. JAMA Psychiatry (2013) 1.95
Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself. Circ Res (2005) 1.91
Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2006) 1.83
The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition. Infect Immun (2005) 1.75
In-training assessment for specialist registrars: views of trainees and trainers in the Mersey Deanery. J R Soc Med (2002) 1.72
Can sutures get wet? Prospective randomised controlled trial of wound management in general practice. BMJ (2006) 1.67
Strain-dependent induction of enterocyte apoptosis by Giardia lamblia disrupts epithelial barrier function in a caspase-3-dependent manner. Infect Immun (2002) 1.63
Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Repair Regen (2002) 1.51
A novel human nicotinic receptor subunit, alpha10, that confers functionality to the alpha9-subunit. Mol Pharmacol (2002) 1.47
Practical guidance: the use of social media in oncology practice. J Oncol Pract (2012) 1.44
PHARMAC and Ventolin in New Zealand. N Z Med J (2005) 1.41
Ca(2+) -stimulated basal adenylyl cyclase activity localization in membrane lipid microdomains of cardiac sinoatrial nodal pacemaker cells. J Biol Chem (2008) 1.40
Factors influencing teaching and learning in the preregistration year. Hosp Med (2003) 1.37
Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf (2007) 1.35
Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1. J Virol (2007) 1.32
Proteinase-activated receptor 1 activation induces epithelial apoptosis and increases intestinal permeability. Proc Natl Acad Sci U S A (2003) 1.32
Risk factors for statin-associated rhabdomyolysis. Pharmacoepidemiol Drug Saf (2007) 1.27
In vitro papillomavirus capsid assembly analyzed by light scattering. Virology (2004) 1.25
Campylobacter jejuni induces transcellular translocation of commensal bacteria via lipid rafts. Gut Pathog (2009) 1.24
Randomized crossover trial of two treatments for sleep apnea/hypopnea syndrome: continuous positive airway pressure and mandibular repositioning splint. Am J Respir Crit Care Med (2002) 1.22
Host parasite interactions and pathophysiology in Giardia infections. Int J Parasitol (2011) 1.21
Monitoring of long-term toxicities of HIV treatments: an international perspective. AIDS (2003) 1.14
SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile. Neuropsychopharmacology (2006) 1.14
Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease. Inflamm Bowel Dis (2010) 1.12
Global Escherichia coli Sequence Type 131 Clade with blaCTX-M-27 Gene. Emerg Infect Dis (2016) 1.12
SGLT-1-mediated glucose uptake protects intestinal epithelial cells against LPS-induced apoptosis and barrier defects: a novel cellular rescue mechanism? FASEB J (2005) 1.12
Becoming a new doctor: a learning or survival exercise? Med Educ (2007) 1.12
A school-based obesity control programme: Project Energize. Two-year outcomes. Br J Nutr (2011) 1.09
A role for Campylobacter jejuni-induced enteritis in inflammatory bowel disease? Am J Physiol Gastrointest Liver Physiol (2009) 1.09
A key claudin extracellular loop domain is critical for epithelial barrier integrity. Am J Pathol (2008) 1.09
Helicobacter pylori activates myosin light-chain kinase to disrupt claudin-4 and claudin-5 and increase epithelial permeability. Infect Immun (2005) 1.08
Src-family kinase dependent disruption of endothelial barrier function by Plasmodium falciparum merozoite proteins. Blood (2007) 1.07
Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice. Gut Pathog (2013) 1.05
Impact of mailed warning to prescribers on the co-prescription of tramadol and antidepressants. Pharmacoepidemiol Drug Saf (2005) 1.03
Anti-inflammatory and cytoprotective actions of hydrogen sulfide: translation to therapeutics. Antioxid Redox Signal (2014) 1.02
Bone bruises associated with ACL rupture: correlation with injury mechanism. Am J Sports Med (2008) 1.02
Development of novel animal infection models for the study of acute and chronic Burkholderia pseudomallei pulmonary infections. Microbes Infect (2008) 1.02
Evidence of endothelial dysfunction in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol (2008) 1.00
Imaging of intrauterine contraceptive devices. J Ultrasound Med (2007) 0.99
Strain-dependent induction of epithelial cell oncosis by Campylobacter jejuni is correlated with invasion ability and is independent of cytolethal distending toxin. Microbiology (2007) 0.99
Enteropathogenic Escherichia coli Tir translocation and pedestal formation requires membrane cholesterol in the absence of bundle-forming pili. Cell Microbiol (2006) 0.98
Epidermal growth factor inhibits Campylobacter jejuni-induced claudin-4 disruption, loss of epithelial barrier function, and Escherichia coli translocation. Infect Immun (2008) 0.98
Vibrio parahaemolyticus inhibition of Rho family GTPase activation requires a functional chromosome I type III secretion system. Infect Immun (2008) 0.96
Reliability and validity of a manual dexterity test to predict preclinical grades. J Dent Educ (2004) 0.95
Effects of chondroitin and glucosamine sulfate in a dietary bar formulation on inflammation, interleukin-1beta, matrix metalloprotease-9, and cartilage damage in arthritis. Exp Biol Med (Maywood) (2005) 0.94
Campylobacter jejuni disrupts protective Toll-like receptor 9 signaling in colonic epithelial cells and increases the severity of dextran sulfate sodium-induced colitis in mice. Infect Immun (2012) 0.93
The role of caspase-3 in lipopolysaccharide-mediated disruption of intestinal epithelial tight junctions. Can J Physiol Pharmacol (2006) 0.93
Interleukin-1 receptor phosphorylation activates Rho kinase to disrupt human gastric tight junctional claudin-4 during Helicobacter pylori infection. Cell Microbiol (2010) 0.93
Infants hospitalised with pertussis: estimating the true disease burden. J Paediatr Child Health (2007) 0.91
Caspases-3, -8, and -9 are required for induction of epithelial cell apoptosis by enteropathogenic E. coli but are dispensable for increased paracellular permeability. Microb Pathog (2007) 0.91
A persistent, productive, and seasonally dynamic vibriophage population within Pacific oysters (Crassostrea gigas). Appl Environ Microbiol (2005) 0.91
SGLT-1-mediated glucose uptake protects human intestinal epithelial cells against Giardia duodenalis-induced apoptosis. Int J Parasitol (2008) 0.90
Baseline measures for a school-based obesity control programme: Project Energize: differences by ethnicity, rurality, age and school socio-economic status. J Paediatr Child Health (2012) 0.89
Tight junctional disruption and apoptosis in an in vitro model of Citrobacter rodentium infection. Microb Pathog (2008) 0.88
LPS/CD14 activation triggers SGLT-1-mediated glucose uptake and cell rescue in intestinal epithelial cells via early apoptotic signals upstream of caspase-3. Exp Cell Res (2006) 0.88
Mechanisms of intestinal tight junctional disruption during infection. Front Biosci (2008) 0.88
Long term platelet responses to Helicobacter pylori eradication in Canadian patients with immune thrombocytopenic purpura. Int J Hematol (2008) 0.88
Multiple clusters of norovirus among shellfish consumers linked to symptomatic oyster harvesters. J Food Prot (2012) 0.88
Coarctation of aorta in a 52-year-old female. J Invasive Cardiol (2008) 0.86
Gonadotropin-releasing hormone induction of apoptosis in the testes of goldfish (Carassius auratus). Endocrinology (2004) 0.85
Amino acid residues within enterohemorrhagic Escherichia coli O157:H7 Tir involved in phosphorylation, alpha-actinin recruitment, and Nck-independent pedestal formation. Infect Immun (2006) 0.85
Anti-HHV-8/KSHV antibodies in infected individuals inhibit infection in vitro. AIDS (2004) 0.85
The role of epithelial malfunction in the pathogenesis of enteropathogenic E. coli-induced diarrhea. Lab Invest (2009) 0.84
5-Hydroxytryptamine contributes significantly to a reflex pathway by which the duodenal mucosa protects itself from gastric acid injury. FASEB J (2006) 0.84
A carboxy-terminal domain of Tir from enterohemorrhagic Escherichia coli O157:H7 (EHEC O157:H7) required for efficient type III secretion. FEMS Microbiol Lett (2005) 0.84
Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations. Pharmacoepidemiol Drug Saf (2009) 0.84
Helicobacter pylori activates calpain via toll-like receptor 2 to disrupt adherens junctions in human gastric epithelial cells. Infect Immun (2011) 0.83
Hydrogen sulfide protects from colitis and restores intestinal microbiota biofilm and mucus production. Inflamm Bowel Dis (2015) 0.83
Interleukin-18 facilitates neutrophil transmigration via myosin light chain kinase-dependent disruption of occludin, without altering epithelial permeability. Am J Physiol Gastrointest Liver Physiol (2011) 0.83
An unusual presentation of a giant tumour-like lesion of the thigh. Acta Orthop Belg (2008) 0.82
Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID. Am J Physiol Gastrointest Liver Physiol (2015) 0.81
Impaired fibrinolysis and traumatic brain injury in mice. J Neurotrauma (2006) 0.81
Giardia duodenalis assemblage-specific induction of apoptosis and tight junction disruption in human intestinal epithelial cells: effects of mixed infections. J Parasitol (2012) 0.81
Proteomic and other mass spectrometry based "omics" biomarker discovery and validation in pediatric venous thromboembolism and arterial ischemic stroke: current state, unmet needs, and future directions. Proteomics Clin Appl (2014) 0.81
Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical use. J Immunol Methods (2012) 0.81
The treatment of multiple myeloma with docetaxel (an ECOG study). Leuk Res (2003) 0.80
Piritrexim in advanced, refractory carcinoma of the urothelium (E3896): a phase II trial of the Eastern Cooperative Oncology Group. Invest New Drugs (2002) 0.80
Tilmicosin-induced bovine neutrophil apoptosis is cell-specific and downregulates spontaneous LTB4 synthesis without increasing Fas expression. Vet Res (2004) 0.80
Neurotoxic envenoming by South American coral snake (Micrurus lemniscatus helleri): case report from eastern Ecuador and review. Trans R Soc Trop Med Hyg (2008) 0.80
Anti-inflammatory effects of retinoids and carotenoid derivatives on caspase-3-dependent apoptosis and efferocytosis of bovine neutrophils. Am J Vet Res (2014) 0.79
Drug safety data mining with a tree-based scan statistic. Pharmacoepidemiol Drug Saf (2013) 0.79
Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment. J Neurovirol (2014) 0.79
Improvement of fundamental movement skills through support and mentorship of class room teachers. Obes Res Clin Pract (2013) 0.79
The impact of cell labelling technique on the retention of indium-labelled platelet imaging for idiopathic thrombocytopenic purpura. Nucl Med Commun (2016) 0.79
Opportunities taken: the need for and effectiveness of secondary care opportunistic immunisation. J Paediatr Child Health (2011) 0.79
Metastasis of basal cell carcinoma in a patient with basal cell carcinoma syndrome. Pathology (2013) 0.78
Small bowel obstruction due to mycosis fungoides: an unusual presentation. Am J Med Sci (2011) 0.78
Novel CD8+ T-Cell Subsets Demonstrating Plasticity in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis (2016) 0.78
Escherichia coli-induced epithelial hyporesponsiveness to secretagogues is associated with altered CFTR localization. Cell Microbiol (2012) 0.77
Assessment of donor fear enhances prediction of presyncopal symptoms among volunteer blood donors. Transfusion (2011) 0.77
Apoptosis-inducing factor contributes to epithelial cell apoptosis induced by enteropathogenic Escherichia coli. Can J Physiol Pharmacol (2011) 0.77
Virology meets Proteomics. Proteomics (2015) 0.77
Heterologous expression, purification, crystallization and preliminary X-ray analysis of Trichoderma reesei xylanase II and four variants. Acta Crystallogr Sect F Struct Biol Cryst Commun (2013) 0.77
A rapid and sensitive assay for paralytic shellfish poison (PSP) toxins using mouse brain synaptoneurosomes. Toxicon (2002) 0.76
Use of pedometers to identify less active children and time spent in moderate to vigorous physical activity in the school setting. J Sci Med Sport (2011) 0.76